IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-α and guarantee asymptomatic clinical status during chronic HTLV-I infection

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 35-44

  Brito Melo, G E A ^a   Peruhype Magalhaes V ^b   Teixeira Carvalho, A ^b,c   Barbosa Stancioli, E F ^d   Carneiro Proietti, A B F ^e   Catalan Soares, B ^e   Ribas, J G ^f   Martins Filho, O A ^b  

^a UNIVERSIDADE FEDERAL DOS VALES DO JEQUITINHONHA E MUCURI   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e FUNDAÇÃO HEMOMINAS   (Brazil)

^f Hospital Sarah Kubitschek   (Brazil)

Author keywords

Asymptomatic carries; HAM TSP; HTLV I; IL 10; TNF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATING DISEASE; FEMALE; FLOW CYTOMETRY; HEALTH STATUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TH1 CELL; VIRUS INFECTION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-10; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845503127     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03252.x     Document Type: Article

References (26)

1. Popovic M, Reitz MS Jr, Sarngadharan MG et al. The virus of Japanese adult T cell leukaemia is a member of the T cell leukaemia virus group. Nature 1982; 300:63-6.
2. Osame M, Usuku K, Izumo S et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1:1031-2.
3. Gessain A, Barin F, Vernant JC et al. Antibodies to human T-lymphotropic virus type I in patients with tropical pararesis. Lancet 1985; 2:407-10.
4. Moore GRW, Traugott U, Sheunberg LC, Raine CS. Tropical spastic paraparesis: a model of virus-induced cytotoxic T cell mediated demyelination? Ann Neurol 1989; 26:523-30.
5. Jacobson S, Zaninovic V, Mora C et al. Immunological finding in neurological diseases: activated lymphocytes in tropical spastic paraparesis. Ann Neurol 1988; 23:S196-200.
6. Yoshida S, Osame M, Kawai H et al. Increased replication of HTLV-I in HTLV-I associated myelopathy. Ann Neurol 1989; 26:331-5.
7. + lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J Neuroimmunol 2000; 102:208-15.
8. Nagai M, Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy. Curr Opin Neurol 2001; 14:381-6.
9. Kuroda Y, Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I associated myelopathy. J Neuroimmunol 1993; 42:223-6.
10. Greten TF, Slasky JE, Kubota R et al. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci USA 1998; 95:7568-73.
11. Brito-Melo GE, Martins-Filho OA, Carneiro-Proietti AB et al. Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil. Grupo Interdisciplinar de Pesquisas Em HTLV. Scand J Immunol 2002; 55:621-8.
12. + lymphocytes directly in peripheral blood of HTLVI-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 1998; 161:482-8.
13. Nishimura M, Maeda M, Yasunaga J et al. Influence of cytokine and mannose biding protein gene polymorphisms on human T cell leukemia virus type I (HTLV-I) provirus load in HTLV-I asymptomatic carriers. Hum Immunol 2003; 64:453-7.
14. Carvalho EM, Bacellar O, Porto AF et al. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic vírus type 1-infected blood donors. J Acquir Immune Defic Syndr 2001; 27:1-6.
15. Brito-Melo GE, Souza JG, Barbosa-Stancioli EF et al. Grupo Establishing phenotypic features associated with morbidity in human T cell lymphotropic virus type 1 infection. Interdisciplinar de Pesquisas em HTLV. Clin Diagn Lab Immunol 2004; 11:1105-10.
16. Guerreiro JB, Porto MAF, Santos SB, Lacerda L, Ho JL, Carvalho EM. Spontaneous neutrophils activation in HTLV-I infected patients. Braz J Infect Dis 2005; 9:510-4.
17. Furuya T, Nakamura T, Fujimoto T et al. Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy. J Neuroimmunol 1999; 95:185-9.
18. Fujimoto T, Nakamura T, Furuya T et al. Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy. Intern Med 1999; 38:717-21.
19. Santos SB, Porto AF, Muniz AL et al. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carries. BCM Infect Dis 2004; 4:7.
20. Umehara FS, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-associated myelopathy. J Neuropathol Exp Neurol 1994; 53:72-7.
21. Bangham CR, Osame M. Cellular immune response to HTLV-1. Oncogene 2005; 24:6035-46.
22. Bieganowska K, Hollsberg P, Buckle GJ et al. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol 1999; 162:1765-71.
23. Biddison WE, Kubota R, Kawanishi T et al. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997; 159:2018-25.
24. Denys A, Udalova IA, Smith C et al. Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. J Immunol 2002; 168:4837-45.
25. Rajasingh J, Bord E, Luedemann C et al. IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J 2006; 20:2112-14.
26. Sabouri AH, Saito M, Lloyd AL et al. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2004; 190:1279-85.